Alharbi, M., Alelyani, M., Walidadham, M., Algarni, A., Algahtani, K., Jaberalfaifi, S. (2018). Updated Review on Surgical Management of Male Hypogonadism. The Egyptian Journal of Hospital Medicine, 70(8), 1356-1361. doi: 10.12816/0044648
Moaz Hassan Alharbi; Mohammad Abdullah Alelyani; Mohammed Walidadham; Ahmad Abdullah Algarni; Khaled Faisal Algahtani; Sultan Jaberalfaifi. "Updated Review on Surgical Management of Male Hypogonadism". The Egyptian Journal of Hospital Medicine, 70, 8, 2018, 1356-1361. doi: 10.12816/0044648
Alharbi, M., Alelyani, M., Walidadham, M., Algarni, A., Algahtani, K., Jaberalfaifi, S. (2018). 'Updated Review on Surgical Management of Male Hypogonadism', The Egyptian Journal of Hospital Medicine, 70(8), pp. 1356-1361. doi: 10.12816/0044648
Alharbi, M., Alelyani, M., Walidadham, M., Algarni, A., Algahtani, K., Jaberalfaifi, S. Updated Review on Surgical Management of Male Hypogonadism. The Egyptian Journal of Hospital Medicine, 2018; 70(8): 1356-1361. doi: 10.12816/0044648
Updated Review on Surgical Management of Male Hypogonadism
In this review, we discuss the treatment options for male hypogonadism and the associated benefits and potential short- and long-term risks. The choice for treatment may depend on the cause of hypogonadism and the desire for maintaining or improving fertility. We also highlight surgical management of male hypogonadism. Comprehensive searching strategy through Well-known medical databases (MIDLINE/ PubMed, and Embase) searching articles that published in English language up to December 2017, and discussing the surgical management of male hypogonadism. Malehypogonadism is identified by the presence of symptoms or signs of male hypogonadism and consistent serum testosterone levels that are below the normally accepted adult male range. Once the medical diagnosis is confirmed, the primary goal of treatment is testosterone substitution to accomplish serum testosterone levels that remain in the mid-adult range and the symptoms and signs of hypogonadism are eliminated. Recent developments led to numerous delivery systems for testosterone. For patients with primary hypogonadism testosterone therapy is the approach of choice. The patient needs to be completely informed about expected benefits and side-effects of the treatment option. The option of the preparation should be a joint decision by a notified patient and the doctor.